Reuters logo
BRIEF-Cascadian Therapeutics reports Q1 loss per share of $0.30
May 9, 2017 / 11:28 AM / 4 months ago

BRIEF-Cascadian Therapeutics reports Q1 loss per share of $0.30

May 9 (Reuters) - Cascadian Therapeutics Inc

* Q1 loss per share $0.30

* Q1 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S

* Expects operating expenses in 2017 to be slightly higher than in 2016, due to rise in activities related to her2climb pivotal trial

* Cash used in operations for 2017 is expected to be approximately $50.0 million to $54.0 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below